128 assets in Stroke Disorder

Therapeutic assets addressing Stroke Disorder, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Aptoll Stroke Disorder	aptaTargets S.L.	P1/2	B (57)
Colchicinum Stroke Disorder	Population Health Research Institute	P3	B (57)
Methylphenidate Stroke Disorder	VA Office of Research and Development	P4	B (57)
3-N-BUTYLPHTHALIDE Stroke Disorder	Qianfoshan Hospital	P4	B (56)
Cyclopofol Stroke Disorder	RenJi Hospital	P4	B (56)
gm1 Stroke Disorder	Xuanwu Hospital, Beijing	P4	B (56)
Lacosamide Stroke Disorder	University of North Carolina, Chapel Hill	P4	B (56)
Prostaglandin E1 Stroke Disorder	The First Hospital of Jilin University	P4	B (56)
Evolocumab Stroke Disorder	Amgen	P4	CCC (55)
Fresh Frozen Plasma Stroke Disorder	Region Skane	P4	CCC (55)
Glenzocimab Stroke Disorder	Assistance Publique - Hôpitaux de Paris	P2/3	CCC (55)
Physiologic Sodium Chloride Solution Stroke Disorder	Zhujiang Hospital	P3	CCC (55)
Adipose Derived Stem Cell Stroke Disorder	University Hospital, Grenoble	P2/3	CCC (54)
Clevidipine Stroke Disorder	Zeenat Qureshi Stroke Institute	P3	CCC (54)
Desferrioxamine B Stroke Disorder	The George Institute	P3	CCC (54)
Dopamine Stroke Disorder	Singapore General Hospital	P4	CCC (54)
Indapamide Stroke Disorder	Beijing Tiantan Hospital	P4	CCC (54)
Maraviroc Stroke Disorder	Emmanuel Carrera	P2/3	CCC (54)
Ramifentanyl Stroke Disorder	University Hospital Heidelberg	P3	CCC (54)
Succinic Acid) Stroke Disorder	POLYSAN Scientific & Technological Pharmaceutical Company	P3	CCC (54)
[18F]AlF-OC Stroke Disorder	Universitaire Ziekenhuizen KU Leuven	P2	CCC (53)
Anakinra Stroke Disorder	Beijing Tiantan Hospital	P2	CCC (53)
Nano2Tm Stroke Disorder	NHS Greater Glasgow and Clyde	P2	CCC (53)
Valproic Acid Stroke Disorder	University of North Carolina, Chapel Hill	P4	CCC (53)
Adezunap Stroke Disorder	Apurano Pharmaceuticals GmbH	P3	CCC (52)
Chirocaine Stroke Disorder	Institut National de la Santé Et de la Recherche Médicale, France	P3	CCC (52)
Dimethyloxobuthylphosphonilmethylate Stroke Disorder	Tatchempharmpreparaty, JSC	P3	CCC (52)
dl-3-butylphthalide Stroke Disorder	Fudan University	P3	CCC (52)
Fosphenytoin Stroke Disorder	University of North Carolina, Chapel Hill	P4	CCC (52)
Immunoglobulin G1 (256-Tyrosine,258-Threonine,260-Glutamic Acid), Anti-(Neural Apoptosis-Regulated Proteinase 1) (Human-Mus Musculus Monoclonal Hrp00130 .Gamma.1-Chain), Disulfide With (3-Valine,5-Serine,49-Serine,66-Aspartic Acid) Human-Mus Musculus Monoclonal Hrp00130 .Kappa.-Chain, Dimer Stroke Disorder	Shanghai East Hospital	P3	CCC (52)
Metformin Stroke Disorder	Spaulding Rehabilitation Hospital	P2	CCC (52)
Byetta Stroke Disorder	Christina Kruuse	P2	CCC (51)
Lactate Stroke Disorder	Centre Hospitalier Universitaire Vaudois	P2	CCC (51)
Modafinil Stroke Disorder	University Health Network, Toronto	P3	CCC (51)
Urokinase-Type Plasminogen Activator Stroke Disorder	Huashan Hospital	P2	CCC (51)
M-Sympathol Stroke Disorder	Zhejiang Cancer Hospital	P3	CCC (50)
Nono-42 Stroke Disorder	The George Institute	P3	CCC (50)
Phenobarbital Stroke Disorder	University of North Carolina, Chapel Hill	P4	CCC (49)
Abelacimab Stroke Disorder	Anthos Therapeutics, Inc.	P2	CCC (48)
Ceftriaxone Stroke Disorder	Tianjin Medical University General Hospital	P2	CCC (48)
Deferiprone Stroke Disorder	University Hospital, Bordeaux	P2	CCC (48)
Drf Stroke Disorder	University Hospital, Lille	P2	CCC (48)
Hyaluronidase Stroke Disorder	Johns Hopkins University	P2	CCC (48)
Mannitol Stroke Disorder	Emmanuel Carrera	P2	CCC (48)
Ndc-002 Stroke Disorder	Dr. Noah Biotech Inc.	P1	CC (47)
Sinemet Pill Stroke Disorder	University of California, Los Angeles	P1/2	CC (44)
Allogeneic Umbilical Cord Blood Stroke Disorder	The Medical Pavilion Bahamas	P1	CC (43)
cg-0255 besylate Stroke Disorder	Shanghai CureGene Pharmaceutical Co., Ltd.	P1	CC (43)
cg-0255 besylate for Stroke Disorder	Shanghai CureGene Pharmaceutical Co., Ltd.	P1	CC (43)
Onabotulinum Toxin A Stroke Disorder	University of Alberta	P1	CC (43)

Showing 51 to 100 of 128 assets

PreviousPage 2 of 3Next